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The ambitious UNAIDS ‘90-90-90’ targets, aiming to end the
AIDS epidemic by the year 2030 [1], are a response to the
profound therapeutic and preventive benefits of HIV treat-
ment. Universal voluntary HIV counselling and testing fol-
lowed by prompt initiation of antiretroviral therapy (ART) for
all those diagnosed HIV-infected, an approach known as
Universal Test and Treat (UTT), is now seen as the primary
means through which the 90-90-90 targets can be achieved.
Beyond the targets, the recently emergent concept of a pre-
vention cascade [2] also recognizes the imperative of “cover-
age” for achieving population-level effects of HIV prevention
interventions, which are needed together with the expansion
of treatment to end the epidemic [3].
Perhaps nowhere else in the world is more momentum
required to bring HIV treatment and prevention to all who
need it than in Africa. The HIV epidemic on the continent has
been concentrated in eastern and southern Africa, where an
estimated 19.4 million adults are living with HIV [4]. Despite
substantial progress in recent years, only approximately 60%
of people living with HIV (PLHIV) in the region were receiving
ART in 2016 [4]; an estimated 45% had a suppressed viral
load as a result of their successful engagement in care in
2015 [5].
These estimates reflect tremendous successes of HIV pre-
vention and care initiatives towards accelerating ART coverage
for sub-Saharan African populations, and many successful
efforts to reach key populations—yet also the sobering reality
that what has been achieved to date has been achieved in
easier to reach populations. A focus by UNAIDS and global
leadership on harder to reach, key populations, that are partic-
ularly important for further scale-up, is laudable; but to date,
inadequate attention has been paid to population mobility, a
major force that challenges the HIV care cascade and threat-
ens the promise of “treatment as prevention” particularly in
high HIV prevalence, resource-limited regions. Ultimately,
strategies to attain the 90-90-90 targets that do not account
for the complex dynamics of mobility in specific settings will
fail to engage successfully with the magnitude of populations
necessary to end the epidemic [6].
There is an urgent need to deepen our understanding of
population mobility, its heterogeneous forms and gender
dimensions in high HIV prevalence areas, its effects on sexual
behaviour and sexual networks, HIV testing and engagement
in HIV care and treatment, and on HIV acquisition and
onward transmission, even as widespread HIV prevention
interventions are underway—indeed, especially in contexts in
which interventions such as UTT are underway. To understand
whether and how mobility attenuates the effectiveness of HIV
prevention and care initiatives is a vital first step towards
identifying the full set of solutions, inclusive of mobile popula-
tions, that will be needed to end the epidemic.
Historically, the spread of HIV in sub-Saharan Africa fol-
lowed the corridors of population movement, as people moved
to expanding urban areas and other places of employment
opportunity [7-10]. Today, mobility continues to place individu-
als at great risk of HIV acquisition as well as onward transmis-
sion [11-13]. The highly gendered nature of that linkage is
well-documented, yet rarely commented upon. Forms of mobil-
ity in sub-Saharan Africa are diverse and complex relative to
those of other regions, and men’s and women’s patterns of
movement significantly differ, with women increasingly partici-
pating in mobility [14-18], as has been seen elsewhere [19-22].
While transcontinental migration from Africa is low [23], the
intra-sub-Saharan African emigration rate represents the lar-
gest south to south movement of people in the world [24].
Data for the study of internal migration have been limited;
however, data from Demographic Surveillance Sites show that
7% to 20% of local populations in surveillance areas, often
over 30% of young adults, have migrated annually in recent
years [14,25]. Rural to urban migration flows do not predomi-
nate in all settings [26]; rather, counter-urbanization [27] and
circulation between rural areas, semi-urban towns, and rural
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perimeters of cities are common [14]. Mobility has positive
benefits for development and is a key driver of economic
growth in southern and eastern Africa: from 50% to 80% of
rural households have at least one migrant member [24], and
the “sending” of a female migrant has been particularly advan-
tageous to the poorest households [23,28,29].
Despite its importance, research on the effects of mobility
in sub-Saharan Africa on HIV care engagement, and on effec-
tiveness of ART as treatment and as prevention, is in its nas-
cency. Existing literature mostly from the global north has
shown that mobility can break bonds between individuals and
HIV care systems [30], thus leading to disengagement from
care, treatment interruption and poor health outcomes.
Research on mobility and care engagement in sub-Saharan
African settings is relatively scarce; thus there are key ques-
tions about the extent to which mobility is contributing to the
gap that exists between the remarkable promise of ART for
large-scale prevention [31-33], and actual engagement in care
[34].
Recent meta-analyses in sub-Saharan African populations
have shown that 30% to 60% of people living with HIV are
lost to follow-up at each step after HIV diagnosis [35-37].
People repeatedly exit and re-enter the care cascade at vari-
ous points [38,39]. Greater attention to the contextual factors
that shape HIV treatment experiences, engagement and out-
comes has recently emerged in social science research on HIV
[40], revealing the complex social realities underlying “bottle-
necks” in the cascade [40]. Yet data have been limited for
investigating the role of mobility in these care cascade short-
falls.
Several meta-analyses and systematic reviews of the litera-
ture examining factors associated with care entry, engagement
and retention [35,37,41–43] show that optimal lifelong
engagement in HIV care can be threatened by a range of fac-
tors at the individual, social, and structural levels. Mobility
affects many of the factors found to contribute to delayed
entry or lapses in care, including psychological factors (e.g.
seeking care away from home because of stigma) [39,44,45],
clinic characteristics (e.g. waiting times) [46,47] and structural
barriers [44,48] such as distance to clinic and transportation
costs [44,47,49,50]. Yet the direct impact of mobility, and the
pathways for this impact, have not been examined in depth
[30,51]. Better measures and methods are needed to under-
stand how mobility affects the ability of individuals to success-
fully navigate the HIV care cascade. This is especially urgent
for sub-Saharan Africa, where levels of mobility are high and
forms of mobility are complex and dynamic. The effects of
mobility on initiatives designed to extend the reach of primary
HIV prevention interventions in these settings are, to date,
unknown— a glaring gap in the literature.
The articles in this supplement of the Journal of the Interna-
tional AIDS Society focus on crucial questions regarding the
forms and dimensions of mobility and the impact on HIV pre-
vention and care initiatives—particularly in Southern and East-
ern Africa, but also in the ‘receiving’ nations in the global
north of sub-Saharan African migrants. This volume includes
contributions from each of the large-scale UTT studies in five
African countries [52], which include HPTN 071 Population
Effects of Antiretroviral Therapy to Reduce HIV Transmission
(PopART), Sustainable East Africa Research in Community
Health (SEARCH); the MaxART (Early Access to ART for All)
implementation study; and the ANRS 12249 Antiretroviral
Treatment as Prevention (TasP) trial. It also includes contribu-
tions from studies outside UTT trial settings on the impacts of
mobility on care engagement. The authors of the papers use
different methods and approaches to identify emergent
themes, key problems and gaps in the study of mobility and
HIV prevention and care and point to potential solutions. The
collection includes quantitative research that advances
approaches towards measurement of diverse forms of mobility
and its impacts, and also highlights the value of qualitative
research for understanding the meaning of factors driving
linkage to HIV treatment and prevention in the context of
migration and mobility.
We observe four major themes across the contributions to
this volume: first, the spatial and temporal dimensions of
mobility are important, because mobility is inherently linked to
time exposed to interventions and services within geographies;
secondly, types of mobility in different populations and set-
tings are diverse and highly gendered, and this heterogeneity
across contexts should inform HIV prevention and treatment
approaches in specific settings; thirdly, while mobility is inter-
twined with other factors that affect engagement in HIV care
and prevention, it often sets into motion a “chain of events”
that leads to disengagement; and fourth, the period following
resettlement in new destinations is one of instability, in which
risk is heightened, disrupting engagement and leading to
‘missed opportunities’ for progress along the prevention and
care cascades. Such missed opportunities must be addressed
through health systems- and policy-level actions. In sum, this
collection speaks to a need for reconfiguration of programs
and services to respond to the challenges to HIV care and
prevention engagement that are presented by the mobility of
populations.
Speaking to the dynamic nature of mobility and the impor-
tance of temporality, Larmarange and colleagues [53] present
findings from the ANRS 12249 Antiretroviral Treatment as
Prevention (TasP) trial, that highlight the effect of population
mobility on temporality of and geographic exposure to the
UTT intervention in rural KwaZulu-Natal, South Africa. The
TasP cluster-randomized trial failed to show a reduction in
HIV incidence at population level when ART was proposed
regardless of CD4 count. The authors describe a dynamic cas-
cade of various degrees of exposure to the trial interventions,
using both calendar (population) and exposure (individual) time
approaches in their analyses, and show that the structural
effects of mobility diluted the impact of the UTT strategy. In a
context of high HIV incidence, the circulation of newly
infected individuals in and out of communities slowed down
TasP efforts to increase ART coverage and population viral
suppression, ultimately attenuating any population-level impact
on HIV incidence.
In their study of population mobility embedded within the
SEARCH trial in rural populations in Kenya and Uganda, Cam-
lin and colleagues [54] describe significant heterogeneity in
mobility across regions in Kenya and Uganda, which correlated
with heterogeneous levels of risk behaviour and HIV preva-
lence observed across the regions: communities with higher
proportions of mobile residents tended to also have higher
HIV prevalence. Mobility may undermine UTT interventions in
high prevalence areas if mobile populations are spending time
exposed outside of their communities and indeed they were
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as follows: both migration and also localized short-term mobil-
ity were associated with higher risk sexual behaviour, espe-
cially among women. Livelihoods requiring mobility for women,
such as market trading, and the fish trade in particular, were
strongly associated with their higher risk sexual behaviour. In
contrast, men’s labour-related mobility was not associated
with higher risk behaviour; their travel for other purposes
(e.g. attending funerals, seeking care, visiting family), was. This
work highlights the need for gender-specific interventions
among mobile populations.
The links between mobility and livelihoods that affect
engagement in HIV care and prevention services and interven-
tions also figure prominently in two contributions from the
PopART trial. Bond and colleagues [55] used longitudinal qual-
itative data focused on the lives of six people living with HIV
in urban Zambia to show the challenges of juggling household
responsibility, livelihood mobility and HIV management. For
five of the six, ongoing engagement in treatment could not be
sustained because of travel. The authors highlight the need
for differential care options which can adjust more to clients’
temporal and spatial realities. Hoddinott and colleagues [56]
used ethnographic and participatory research to describe pat-
terns of ‘household fluidity’ in the Western Cape of South
Africa, and explored how movements in and out of households
to ensure livelihoods and social support shape HIV service
access. With their conceptualization of ‘fluidity’, the authors
challenge conventional sociological concepts of households,
that is, they are not static, contained or bounded as the typi-
cal measures would suggest. Echoing the recommendations of
Bond and colleagues, the authors call for “responsive, flexible
health service delivery systems designed to support continuity
in care across many shifts in client circumstances.”
Shabalala and colleagues [57] present findings from a
mixed methods study to improve understanding of care
retention among ART clients in the MaxART implementation
study in Swaziland. The authors examined associations
between socio-demographic characteristics and retention, and
conducted in-depth interviews with clients who were lost-to-
follow-up from the study to explore their reasons for leaving
care. Mobility, particularly relocations to another community
far from the facility where the client initially obtained ART,
was described by study participants as the first step in a
complex chain of events that affected retention in care. Sev-
eral often-intersecting reasons for discontinuing ART also
mattered, including “harsh treatment by health care workers”,
ART side effects, stigma, and food insecurity. These findings
provide further evidence in support of Ware’s conceptualiza-
tion of care disengagement as a process through which
missed visits, and ensuing reluctance to return, can erode
patients’ feelings of connectedness to care over time [39].
They also expand upon this conceptualization by documenting
how migration events can trigger the chain of events that
leads to disengagement.
Expanding upon this theme, studies conducted outside of
UTT trial contexts highlight how the period following resettle-
ment in new destinations is a period of instability in which
behavioural risks of HIV acquisition are heightened, and
engagement in care and prevention is disrupted, leading to
missed opportunities for improving the prevention and care
cascades. Fakoya and colleagues [58] present findings from a
study of care engagement among migrants living with HIV in
Europe. Using data from 57 HIV clinics in nine countries, the
authors investigated the barriers and facilitators to HIV test-
ing, and assessed the current treatment and healthcare needs
of migrants living with HIV in Europe. Noting that immigrants
are overrepresented in the European HIV epidemic, the
authors present evidence suggesting that exposure to HIV
after migrating accounts for a substantial proportion of infec-
tions among migrants, and that opportunities for HIV preven-
tion are being missed. They call for a greater attention to the
HIV prevention needs of immigrants to Europe, including
interventions to reduce HIV acquisition among migrant gay
and bisexual men, and to expand HIV testing opportunities for
migrant heterosexual men and women.
Two articles in this volume examine women’s migration in
the context of pregnancy. Clouse and colleagues [59] present
findings from a mixed methods study to identify drivers and
types of mobility among pregnant and postpartum women
living with HIV in the Johannesburg area in South Africa.
They examine long-distance travel of mothers and infants
before and after delivery, finding that the frequent mobility
in the peripartum period “underscores the challenge of
ensuring a continuity of HIV care in a fragmented health
care system that is not adapted for a mobile population.” In
another setting in South Africa (Cape Town), Phillips and col-
leagues [60] also examined the mobility of women attending
an integrated antenatal-ART clinic. Using routine electronic
health data (including laboratory testing, ART dispensing and
clinic visits) to measure the movements and access points of
pregnancy and postpartum women, the authors show that a
substantial proportion of women do not link to postpartum
care, and among those who do, long-term retention remains
a challenge as women move to a wide variety of facilities
locally and nationally.
Vearey [61] offers a Commentary that speaks to a need for
improving the policy environment to address better the HIV
prevention and care needs of mobile populations. She explores
challenges and strategic opportunities for “re-setting” the pol-
icy agenda on migration and HIV in southern Africa, specifi-
cally in the policy environment of the Southern African
Development Community (SADC) – a region associated with
high levels of migration, and home to the largest population of
people living with HIV globally. Drawing upon policy review,
empirical data, and on-going participant observation within
local, regional and global policy processes, Vearey shows how
current policy processes have the potential to undermine
efforts to improve the global responses to migration and HIV.
She argues that, “without mainstreaming migration, HIV pro-
grammes will continue to struggle, and key health targets will
not be met.”
Lastly, in our Viewpoint, the editors have expanded on two
specific organizing concepts that have emerged from our work
on this volume: the time scales of mobility, and migrants’ sex-
ual networks. Temporal scales of population mobility are com-
plex, sexual risk behaviour can change in relation to the timing
of migration, and timing of migration can interact with timing
of, and exposure to, HIV prevention efforts. Additionally, the
timing, sequence and spatial scale of migrant’s sexual net-
works can mitigate intervention effectiveness. Cassels, Camlin
and Seeley [62] argue that focusing on temporal patterns of
mobility and network characteristics will not only help to
explain why population mobility presents a challenge for HIV
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prevention and care, but can be leveraged to improve future
interventions.
The collection of articles in this volume contribute to fram-
ing a future policy and research agenda. Treatment access is a
key area of concern: how can migrants sustain their care in
the myriad destinations to which they travel? What interven-
tions, policies, or health systems improvements are needed to
maximize the engagement of mobile individuals in HIV care?
Recognising the need for approaches that are responsive to
diversity, that risk and opportunities for care may be affected
by gender, age, sexual identity and ethnicity, is essential if hard
to reach populations are to be reached by UTT. What possibil-
ities exist for reconceptualising care delivery to address these
challenges?
Mobile populations may be among those who stand to benefit
the most from new models of differentiated care or differenti-
ated service delivery, which aim to simplify and adapt HIV ser-
vices across the cascade to better meet the needs of PLHIV
and reduce burdens on health systems [63]. These models
include patient-led community adherence groups, healthcare
worker-managed groups known as adherence clubs, fast-track
or multi-month scripting, mobile outreach, and community drug
distribution points. To the extent that these models can be
informed by an understanding of the needs of mobile women
and men living with HIV, they hold promise for engaging and
retaining these populations who struggle to fit their needs to
the requirements of clinic-based HIV care systems.
In addition, mobile populations stand to benefit from
improved therapeutic technologies such as long-acting ART as
well as longer-acting formulations of biomedical prevention
technologies such as Pre-Exposure Prophylaxis (PrEP), and
expansion of the delivery of these technologies beyond clinic
settings into communities and key migration destinations and
transit hubs. Structural and behavioural interventions to facili-
tate demand are needed to complement these ‘supply side’
interventions [2]. Without such innovations, migrants will con-
tinue to be left behind in the quest to end the AIDS epidemic.
We hope that this collection stimulates focus and commitment
towards meeting this critical public health challenge.
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